Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition
Open Access
- 14 November 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (47) , 6257-6267
Abstract
The rise of multi- and even totally antibiotic resistant forms of Mycobacterium tuberculosis underlines the need for new antibiotics. The pathogen is resistant to β-lactam compounds due to its native serine β-lactamase, BlaC. This resistance can be circumvented by administration of a β-lactamase inhibitor. We studied the interaction between BlaC and the inhibitor clavulanic acid. Our data show hydrolysis of clavulanic acid and recovery of BlaC activity upon prolonged incubation. The rate of clavulanic acid hydrolysis is much higher in the presence of phosphate ions. A specific binding site for phosphate is identified in the active site pocket, both in the crystalline state and in solution. NMR spectroscopy experiments show that phosphate binds to this site with a dissociation constant of 30 mM in the free enzyme. We conclude that inhibition of BlaC by clavulanic acid is reversible and that phosphate ions can promote the hydrolysis of the inhibitor.Keywords
This publication has 42 references indexed in Scilit:
- Easier cure for resistant TBScience, 2017
- Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2015
- Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor CombinationsAntimicrobial Agents and Chemotherapy, 2013
- Molecular Biology of Drug Resistance in Mycobacterium tuberculosis2012
- Reappraising the use of β-lactams to treat tuberculosisExpert Review of Anti-infective Therapy, 2012
- Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In VivoAntimicrobial Agents and Chemotherapy, 2012
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosisScience, 2009
- Activity of Amoxicillin/Clavulanate in Patients with TuberculosisClinical Infectious Diseases, 1998
- Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?Antimicrobial Agents and Chemotherapy, 1995
- A standard numbering scheme for the class A β-lactamasesBiochemical Journal, 1991